| 1 |
30451372 | Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. | 2019 Jan |
2 |
| 2 |
19967165 | Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis. | 2009 Dec |
1 |
| 3 |
11431944 | Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass. | 2001 May |
2 |
| 4 |
1806461 | Intramedullary multiple hematomas in siblings with congenital alpha-2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid. | 1991 |
1 |
| 5 |
1693450 | Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation. | 1990 Apr 15 |
1 |
| 6 |
3334852 | Binding site of alpha 2-plasmin inhibitor to plasminogen. | 1988 Jan 4 |
1 |
| 7 |
3988955 | A bleeding disorder due to deficiency of alpha 2-antiplasmin. | 1985 Apr |
1 |
| 8 |
7095605 | Congenital deficiency of alpha 2-plasmin inhibitor in three sisters. | 1982 |
1 |
| 9 |
6447383 | Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot. | 1980 Feb 29 |
1 |